Considering Cushing’s Disease: Yours to Keep or Refer?Scott Urquhart, PA–C, DFAAPA1. Review the obvious and subtle clinical presentations of hypercortisolemia and other clinical conditions that resemble it.2. Describe the work-up and treatment of hypercortisolemia as it relates to Cushing’s Syndrome /disease and appropriate endocrine referral.

New Therapies for the Treatment of Hypercholesterolemia: How to Use ThemJoyce L. Ross, MSN, ANP, CLS, CRNP, FPCNA, FNLA1. Recall classes of dyslipidemic medications and the appropriate use for each.2. Identify how treatment decisions apply to the most recent clinical guidelines.3. Apply current knowledge to cases.

Insulin Overview: Which Type and WhyDavida F. Kruger, MSN, APRN–BC, BC–ADM1. Identify a variety of insulin options available to treat people with diabetes.2. Verbalize the difference in potency between u-100 insulin, and u-500 insulin.3. Identify insulin available in vials and insulin pens.4. Verbalize insulin on the horizon. 5. Effectively write a prescription for insulin.

Case Studies continued: Moving Beyond Your Comfort ZonePresenters: Donna Jornsay, MS, BSN, CPNP, CDE, BC-ADM, CDTCDavida F. Kruger, MSN, APRN–BC, BC–ADM1. Through the use of a case presentation the attendee will be able to verbalize when and how to initiate insulin as well as tactics to support the patient to be successful.2. Attendees will be able to verbalize the variety of insulins available as well as devices available to administer.3. Attendees will be able to recognize potential barriers to starting insulin and the support and education the patient requires to be successful.

Nephrology Secrets: Diabetic Kidney Disease (DKD) and HypertensionKim Zuber, PA-C, MS1. Identify the stages of kidney disease highlighting risk factors that predict progression of CKD.2. Highlight goals of diabetic management from multiple sources including kidney and diabetic experts.3. Discuss urine testing with emphasis on acceptable lab deviations that may affect patient care.4. Using CKD stages, identify diabetic medications that are safe to use in each stage including FDA alerts.5. Using a sample patient, discuss who/when/how to treat the CKD diabetic patient.

Type 2 Diabetes, Pre-Diabetes and Reproductive ConcernsDonna Jornsay, MS, BSN, CPNP, CDE, BC-ADM, CDTC1. Participants will describe the pathophysiology of type 2 diabetes in children.2. Participants will identify one strategy for decreasing obesity in children.3. Participants can state the number of hours of physical activity needed to prevent pre-diabetes from becoming type 2 diabetes in children.4. Identify the complications related to presentational DM that can affect mom and baby during pregnancy.

Key Points to Know for Emerging Adults with Type 1 DiabetesDonna Jornsay, MS, BSN, CPNP, CDE, BC-ADM, CDTC1. Participants will be able to identify one behavior of emerging adults which threatens glycemic control.2. Participants will state one practice change they can implement to assist this group in maintaining/establishing control.

Expert Tips on Evaluating Thyroid NodulesChris Sadler, MA, PA–C, CDE, DFAAPA1. Discuss how common thyroid nodules are in the general population and that most typify benign disease.2. List ultrasound characteristics that increase suspicion of malignant disease.3. Discuss appropriate ongoing follow-up of thyroid nodules.4. Describe laboratory testing recommended for the work up of a newly found thyroid nodule(s).

Mind and Body: The Vicious Cycle of Depression in Diabetes and Chronic IllnessEllen D. Mandel, DMH, MPA, MS, PA–C, RD, CDE1. List the incidence and predictors of depression and diabetes.2. Correlate disordered eating with diabetes risk.3. Explain the intersection of dementia, depression and diabetes.4. Describe the effect of PTSD on diabetes.

Cold Case Studies in Renal Medication Dosing: The Good, the Bad and the IatrogenicKim Zuber, PAC, MS1. By CKD stage, review common medications taken by CKD patients.2. By CKD stage, review common dosing errors and the pathological rationale for medication selection.3. Using patient examples, discuss medication errors commonly found for CKD patients.4. Give a quick overview of the OTC meds dangerous for the CKD patient.5. Discuss the relationship between AKI and CKD for the non-nephrology practitioner.

Osteoporosis: Sticks and Stones May or May Not Break My Bones?Richard S. Pope, MPAS, PA–C, DFAAPA, CPAAPA1. Apply NOF/WHO criteria to make the diagnosis of osteoporosis.2. Decipher what tests are needed in individual patients given their history and risk factors for fracture.3. Develop strategies to manage your patient’s skeletal health and decrease their risk of fracture. 3. Compare and critique different mechanisms of action for FDA approved OP medications. 4. Summarize the best choices for treatment given specific patient examples.